Behcet’s disease presenting as intracranial hypertension due to cerebral venous thrombosis  by Al Abdulsalam, Omar et al.
Saudi Journal of Ophthalmology (2015) 29, 81–84Case ReportBehcet’s disease presenting as intracranial hypertension due
to cerebral venous thrombosisPeer review under responsibility
of Saudi Ophthalmological Society,
King Saud University Production and hosting by Elsevier
Access this article onlin
www.saudiophthaljourn
www.sciencedirect.com
Received 17 August 2014; accepted 18 September 2014; available online 2 October 2014.
a Department of Ophthalmology, College of Medicine, University of Dammam, Dammam, Saudi Arabia
b Department of Ophthalmology, King Abdulaziz Hospital-Al Ahsa-National Guard Health Affairs, Saudi Arabia
c Department of Dermatology, College of Medicine, University of Dammam, Dammam, Saudi Arabia
⇑ Corresponding author at: Department of Ophthalmology, College of Medicine, University of Dammam, P.O. Box 31010, Khobar 31952, Saudi
Mobile: +966 507017777.
e-mail address: ahmedalhabash@gmail.com (A. Al Habash).Omar Al Abdulsalam a,b, Ahmed Al Habash a,⇑, Faisal Malik a, Inaam Aldamanhori cAbstractThe non-parenchymal central nervous system’s (CNS) involvement in Behcet’s disease (BD) is considered rare. We herein report a
case of BD complicated by intracranial hypertension (ICH) due to cerebral venous thrombosis (CVT) in a 25-year-old Saudi male.
Our patient presented with a four-week history of increasingly severe headache, nausea and diplopia, which were preceded by
previous recurrent intermittent oral and genital ulcers, history suggestive of acneiform lesions and arthralgia over the past two
years. Ophthalmic examination disclosed normal visual acuity (20/20) in both eyes with bilateral 6th nerve palsy and papilledema.
Both eyes showed no signs of anterior or posterior segment inflammation. Oral and genital ulcers were found on physical exam-
ination with no other lesions. Magnetic resonance imaging (MRI) and magnetic resonance venography (MRV) of the brain showed
lack of flow in the right transverse and sigmoid dural sinuses suggestive of venous thrombosis. On lumbar puncture, the opening
pressure was greatly raised. After a comprehensive screening for prothrombotic conditions, a diagnosis of BD with ICH due to CVT
was made. The patient was then treated by oral prednisolone, azathioprine, colchicine, cyclosporine, as well as anticoagulation,
which resulted in significant clinical improvement.
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The first description of BD is attributed to Hulusi Behçet,
who described the cases of oral and genital ulcers with
hypopyon uveitis. The disease has since been recognized
as a vasculitis with multiple disease manifestations.1 BD
has a distinct geographical distribution along the ancient
trading route known as the ‘Silk Route’, extending from
the Mediterranean countries to the Far East. This suggests
that the etiological agent(s), including several genetic fac-
tors such as HLA-B51 had spread through this way.2 Ithas been reported, however, from most countries across
the globe.
It is characterized by recurrent oral aphthae and any of
several systemic manifestations including genital ulcers, ocu-
lar disease, skin lesions, neurological manifestations, vascular
disease and arthritis.3
Central nervous system’s involvement in BD includes paren-
chymal and non-parenchymal (i.e. cerebral venous thrombosis
or arterial aneurysm) lesions.4 The clinical spectrum of CVT, its
treatmentmodalities, response to treatment and its long-term
outcome are still uncertain due to the small number of patients
reported in the literature up till now.5e:
al.com
Arabia.
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We report a 25-year-old Saudi male, presented in Novem-
ber 2013 with a four-week history of increasingly severe
headache, nausea and diplopia. A detailed medical history
revealed that the patient had previous recurrent oral and
genital ulcers, pimples on his back and arms suggestive of
acneiform lesions and arthralgia in both knees and wrists over
the past two years.
On physical examination, the vital signs were within nor-
mal. Ophthalmic exam showed a best corrected visual acuity
(BCVA) of 20/20 in both eyes, and bilateral 6th nerve palsy
with limitation of abduction (3) OD and (1) OS. The pupils
were found to be regular and reactive with no afferent pupil-
lary defect in both eyes. The intraocular pressure readings
were 13 and 15 mmHg in the right and left eye, respectively.
Anterior segment examination and vitreous showed no signs
of inflammation. Fundoscopy revealed bilateral papilledema
with no evidence of retinal vasculitis (Fig. 1). Visual field test
using Humphrey perimeter showed bilateral enlarged blind
spots (Fig. 2). Color vision was normal. Other aspects of the
neurological examination were within normal. The remainder
of physical examination was unremarkable except for multi-
ple ulcers over the tongue and buccal mucosa, with a scrotal
scar.
The initial non-contrast computerized tomography (CT)
scan of the brain and orbit was normal. MRI of the brain withFigure 2. Humphrey visual field showin
Figure 1. Papilledema without the evidence of posteand without contrast and a magnetic resonance venography
MRV were done and showed lack of flow in the right trans-
verse and sigmoid sinuses suggestive of CVT (Fig. 3). A lum-
bar puncture was performed and was remarkable for the
opening pressure of 460 mm H2O with normal cerebrospinal
fluid (CSF) composition.
Initial laboratory tests showed hemoglobin 11.1 g/dl, ESR
120 mm/hr and C-reactive protein 0.4 mg/dl. Normal or neg-
ative investigations included WBC, platelets, prothrombin
time, antithrombin III, factor V, factor IX, factor XI, factor VIII,
protein C, protein S, homocysteine, anticardiolipin, anti-dou-
ble-stranded DNA, ANA, rheumatoid factor, liver function
tests, renal function tests, lipid profile, urine analysis, sickle
cell screening test, chest X-ray, CT scan of the chest, electro-
cardiogram (ECG) and echocardiogram.
After neurological and rheumatological consultations, a
diagnosis of BD with intracranial hypertension secondary to
CVT was made. The patient was started on prednisolone
60 mg/day, warfarin 5 mg/day, azathioprine 100 mg/day,
and colchicine 0.5 mg twice daily with improvement of the
headache during the first 2 weeks. Diplopia was managed
by 25D (OD) and 10D (OS) Fresnel prisms. Cyclosporine
100 mg/day was added subsequently and the patient was
maintained on 10 mg prednisolone daily. HLA-B51 typing
was done and found to be positive.
After a nine-month follow up, the 6th nerve palsy and
papilledema have resolved, with no recurrence of the oralg enlarged blind spot in both eyes.
rior uveitis or vasculitis in the initial presentation.
Figure 3. Magnetic resonance venogram (MRV) demonstrating lack of
flow in the right transverse and sigmoid sinuses suggestive of CVT.
(Yellow arrowhead depicts lack of flow in the sinuses).
Table 1. Diagnostic criteria for Behcet’s disease (International Study Group
for Behcet’s Disease, 1990).
Recurrent oral aphtae: At least three times in a year
Plus any two of
Genital ulcerations: Active lesion or scar
Skin lesions: Erythema nodosum, folliculitis,
other ulcerations
Eye involvement: Anterior or posterior uveitis,
or retinal vasculitis
Positive pathergy test: Skin hyper-reactivity to pinprick
(sterile pustule formed in 24–48 h)
BD presenting as ICH 83or genital ulcers, skin lesions or arthralgia using the above
regimen.Discussion
BD is a clinical diagnosis based on the presence of charac-
teristic manifestations.6 The International Study Group (ISG)
published ‘‘diagnostic’’ criteria for BD (Table 1) in 1990,7
though these are actual classification criteria used to assure
the similarity of patient groups in studies. As such, they lack
sensitivity for the diagnosis in some patients. CNS manifesta-
tions are not considered in these criteria, but should be con-
sidered in securing the diagnosis.8
During a 2-year period, our patient suffered from recur-
rent intermittent oral and genital ulcers, acneiform eruptions,
and arthralgia. These manifestations met the ISG criteria for
BD. The neurological findings in our patient including 6th
nerve palsy and papilledema with symptoms of headache
and nausea were attributed to the raised intracranial pres-
sure. The MRI/MRV results confirmed our diagnosis of CVT,
which was the cause of ICH.
There are two major types of neurologic involvement in
BD: parenchymal and non-parenchymal. These two types
rarely occur in the same individual.9
In the parenchymal type, the brain stem, hemispheres,
meninges, and spinal cord can be affected either individuallyor in combination.10 Clinical presentations include bilateral
pyramidal symptoms, mental changes, hemiparesis, cranial
nerve palsies, sphincter disturbances, and brain stem symp-
toms. Isolated psychiatric symptoms and peripheral nerve
involvement are rare.11
Neurological involvement in BD may also occur as a non-
parenchymal form, which includes CVT. In this form, patients
may present with symptoms and signs of increased intracra-
nial pressure including headache and papilledema, or with
an acute meningeal syndrome. Less commonly, patients can
present with an acute stroke resulting from arterial thrombo-
sis, dissection or aneurysm. MRV is the imaging modality of
choice when CVT is suspected. Lumbar puncture demon-
strates a high CSF opening pressure, but fluid analysis is
normal.12
Although neurological manifestations typically appear
with or following other systemic symptoms of BD, they may
present initially, posing a diagnostic challenge.1
Treatment of BD is focused on the inflammatory mecha-
nism. Glucocorticoids, immunosuppressive agents such as
azathioprine and cyclophosphamide, as well as immunomod-
ulatory agents are the most commonly used drugs.13 Man-
agement of cerebral venous thrombosis is directed toward
the underlying inflammatory process and the use of anticoag-
ulation. Although treatment of skin-mucosa manifestations,
eye disease and pulmonary artery aneurysm has improved
significantly in the past decades, the treatment of central ner-
vous system lesions is still problematic.14 Our protocol was to
use both oral prednisolone and immunosuppressive agents
(azathioprine and cyclosporine) in addition to warfarin. The
patient responded well to the treatment with significant
clinical improvement.
In conclusion, we have reported this case to highlight the
importance of including BD as a cause of CVT, especially in a
young patient where there is a high index of clinical suspi-
cion. We also aimed to increase the awareness of neurologi-
cal manifestations of BD among physicians.Conflict of interest
The authors declared that there is no conflict of interest.References
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